Which has better valuation and earnings, RVT or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Royce Small-Cap Trust N/A N/A N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A N/A N/A

Is RVT or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Royce Small-Cap Trust N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has preferable earnings & valuation, HQL or TY?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors N/A N/A N/A N/A N/A Tri Continental N/A N/A N/A N/A N/A

Is HQL or TY more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Tri Continental N/A N/A N/A

Do analysts rate TOP or HQL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TOP Financial Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 abrdn Life Sciences Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, TOP or HQL?

abrdn Life Sciences Investors has lower revenue, but higher earnings than TOP Financial Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TOP Financial Group $4.72M 383.70 -$1.17M -$0.02 N/A abrdn Life Sciences Investors N/A N/A N/A N/A N/A

Is TOP or HQL more profitable?

Company Net Margins Return on Equity Return on Assets TOP Financial Group N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has higher valuation and earnings, NUV or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nuveen Municipal Value Fund N/A N/A N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A N/A N/A

Is NUV or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Nuveen Municipal Value Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has higher earnings and valuation, HQL or USA?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors N/A N/A N/A N/A N/A Liberty All-Star Equity Fund N/A N/A N/A N/A N/A

Is HQL or USA more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Liberty All-Star Equity Fund N/A N/A N/A

abrdn Life Sciences Investors (HQL) Competitors

$19.82 +0.06 (+0.30%)

Closing price 03:59 PM Eastern

Extended Trading

$19.84 +0.02 (+0.08%)

As of 07:30 PM Eastern

Compare

HQL vs. RVT, TY, TOP, NUV, and USA

Should you buy abrdn Life Sciences Investors stock or one of its competitors? abrdn Life Sciences Investors's main competitors and comparable companies include Royce Small-Cap Trust (RVT), Tri Continental (TY), TOP Financial Group (TOP), Nuveen Municipal Value Fund (NUV), and Liberty All-Star Equity Fund (USA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Royce Small-Cap Trust (NYSE:RVT) and abrdn Life Sciences Investors (NYSE:HQL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

Royce Small-Cap Trust has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

25.6% of Royce Small-Cap Trust shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 0.1% of Royce Small-Cap Trust shares are held by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Royce Small-Cap Trust pays an annual dividend of $1.77 per share and has a dividend yield of 10.1%. abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 11.3%.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Royce Small-Cap Trust	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Royce Small-Cap Trust	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

In the previous week, Royce Small-Cap Trust had 2 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 3 mentions for Royce Small-Cap Trust and 1 mentions for abrdn Life Sciences Investors. Royce Small-Cap Trust's average media sentiment score of 0.91 beat abrdn Life Sciences Investors' score of -1.00 indicating that Royce Small-Cap Trust is being referred to more favorably in the media.

Company	Overall Sentiment
Royce Small-Cap Trust	Positive
abrdn Life Sciences Investors	Negative

Summary

Royce Small-Cap Trust and abrdn Life Sciences Investors tied by winning 3 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Tri Continental?

abrdn Life Sciences Investors (NYSE:HQL) and Tri Continental (NYSE:TY) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Tri Continental	N/A	N/A	N/A

abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 11.3%. Tri Continental pays an annual dividend of $1.11 per share and has a dividend yield of 3.2%.

In the previous week, Tri Continental had 1 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 2 mentions for Tri Continental and 1 mentions for abrdn Life Sciences Investors. Tri Continental's average media sentiment score of 1.03 beat abrdn Life Sciences Investors' score of -1.00 indicating that Tri Continental is being referred to more favorably in the news media.

Company	Overall Sentiment
abrdn Life Sciences Investors	Negative
Tri Continental	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Tri Continental	N/A	N/A	N/A	N/A	N/A

abrdn Life Sciences Investors has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Tri Continental has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 10.2% of Tri Continental shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Comparatively, 8.7% of Tri Continental shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

abrdn Life Sciences Investors and Tri Continental tied by winning 3 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to TOP Financial Group?

TOP Financial Group (NASDAQ:TOP) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

0.3% of TOP Financial Group shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

TOP Financial Group has a beta of -1.08, suggesting that its share price is 208% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
TOP Financial Group	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TOP Financial Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
abrdn Life Sciences Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, TOP Financial Group had 5 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 6 mentions for TOP Financial Group and 1 mentions for abrdn Life Sciences Investors. TOP Financial Group's average media sentiment score of 0.99 beat abrdn Life Sciences Investors' score of -1.00 indicating that TOP Financial Group is being referred to more favorably in the media.

Company	Overall Sentiment
TOP Financial Group	Positive
abrdn Life Sciences Investors	Negative

abrdn Life Sciences Investors has lower revenue, but higher earnings than TOP Financial Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TOP Financial Group	$4.72M	383.70	-$1.17M	-$0.02	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A

Summary

TOP Financial Group beats abrdn Life Sciences Investors on 4 of the 7 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Nuveen Municipal Value Fund (NYSE:NUV) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Nuveen Municipal Value Fund pays an annual dividend of $0.13 per share and has a dividend yield of 1.5%. abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 11.3%.

Company	Net Margins	Return on Equity	Return on Assets
Nuveen Municipal Value Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

22.5% of Nuveen Municipal Value Fund shares are owned by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 1.0% of Nuveen Municipal Value Fund shares are owned by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Nuveen Municipal Value Fund. MarketBeat recorded 1 mentions for abrdn Life Sciences Investors and 0 mentions for Nuveen Municipal Value Fund. Nuveen Municipal Value Fund's average media sentiment score of 0.00 beat abrdn Life Sciences Investors' score of -1.00 indicating that Nuveen Municipal Value Fund is being referred to more favorably in the media.

Company	Overall Sentiment
Nuveen Municipal Value Fund	Neutral
abrdn Life Sciences Investors	Negative

Nuveen Municipal Value Fund has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuveen Municipal Value Fund	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A

Summary

abrdn Life Sciences Investors beats Nuveen Municipal Value Fund on 5 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

abrdn Life Sciences Investors (NYSE:HQL) and Liberty All-Star Equity Fund (NYSE:USA) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 11.3%. Liberty All-Star Equity Fund pays an annual dividend of $0.67 per share and has a dividend yield of 11.4%.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Liberty All-Star Equity Fund	N/A	N/A	N/A

In the previous week, Liberty All-Star Equity Fund had 4 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Liberty All-Star Equity Fund and 1 mentions for abrdn Life Sciences Investors. Liberty All-Star Equity Fund's average media sentiment score of 1.10 beat abrdn Life Sciences Investors' score of -1.00 indicating that Liberty All-Star Equity Fund is being referred to more favorably in the news media.

Company	Overall Sentiment
abrdn Life Sciences Investors	Negative
Liberty All-Star Equity Fund	Positive

abrdn Life Sciences Investors has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Liberty All-Star Equity Fund has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Liberty All-Star Equity Fund	N/A	N/A	N/A	N/A	N/A

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 10.0% of Liberty All-Star Equity Fund shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 0.1% of Liberty All-Star Equity Fund shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Liberty All-Star Equity Fund beats abrdn Life Sciences Investors on 4 of the 6 factors compared between the two stocks.

Get abrdn Life Sciences Investors News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQL vs. The Competition

Export

Metric	abrdn Life Sciences Investors	Capital Markets Industry	Finance Sector	NYSE Exchange
Market Cap	$600.86M	$5.53B	$14.10B	$23.39B
Dividend Yield	11.34%	7.50%	5.95%	3.58%
P/E Ratio	N/A	30.29	25.55	28.59
Price / Sales	N/A	1,237.52	511.95	21.13
Price / Cash	N/A	47.92	30.30	19.47
Price / Book	N/A	3.53	2.75	4.75
Net Income	N/A	$417.39M	$1.32B	$1.07B
7 Day Performance	-3.51%	-1.56%	-1.21%	-2.38%
1 Month Performance	-6.35%	-2.02%	-0.30%	-3.62%
1 Year Performance	40.12%	2.17%	8.20%	9.75%

abrdn Life Sciences Investors Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQL abrdn Life Sciences Investors	N/A	$19.82 +0.3%	N/A	+39.4%	$600.86M	N/A	N/A	N/A	Negative News Short Interest Increase
RVT Royce Small-Cap Trust	N/A	$18.20 -1.4%	N/A	+10.1%	$2.26B	N/A	N/A	50	Ex-Dividend Short Interest Increase
TY Tri Continental	N/A	$35.21 +0.0%	N/A	+3.1%	$1.87B	N/A	N/A	N/A	Positive News
TOP TOP Financial Group	0.3888 of 5 stars	$15.11 -1.0%	N/A	+116.7%	$1.85B	$4.47M	N/A	11
NUV Nuveen Municipal Value Fund	N/A	$8.77 -1.1%	N/A	-2.2%	$1.84B	N/A	N/A	640

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HQL) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, TY, TOP, NUV, and USA

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Summary

How does abrdn Life Sciences Investors compare to Tri Continental?

Summary

How does abrdn Life Sciences Investors compare to TOP Financial Group?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, TY, TOP, NUV, and USA

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Which has more volatility and risk, RVT or HQL?

Do insiders and institutionals have more ownership in RVT or HQL?

Is RVT or HQL a better dividend stock?

Which has better valuation and earnings, RVT or HQL?

Is RVT or HQL more profitable?

Does the media favor RVT or HQL?

Summary

How does abrdn Life Sciences Investors compare to Tri Continental?

Is HQL or TY more profitable?

Is HQL or TY a better dividend stock?

Does the media refer more to HQL or TY?

Which has preferable earnings & valuation, HQL or TY?

Which has more volatility and risk, HQL or TY?

Do institutionals and insiders believe in HQL or TY?

Summary

How does abrdn Life Sciences Investors compare to TOP Financial Group?

Do institutionals and insiders believe in TOP or HQL?

Which has more volatility and risk, TOP or HQL?

Is TOP or HQL more profitable?

Do analysts rate TOP or HQL?

Does the media favor TOP or HQL?

Which has higher valuation and earnings, TOP or HQL?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Is NUV or HQL a better dividend stock?

Is NUV or HQL more profitable?

Do institutionals and insiders believe in NUV or HQL?

Does the media favor NUV or HQL?

Which has more risk and volatility, NUV or HQL?

Which has higher valuation and earnings, NUV or HQL?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Is HQL or USA a better dividend stock?

Is HQL or USA more profitable?

Does the media prefer HQL or USA?

Which has more volatility and risk, HQL or USA?

Which has higher earnings and valuation, HQL or USA?

Do institutionals and insiders have more ownership in HQL or USA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools